Variant LovD polypeptides and their uses
US-9181570-B2 · Nov 10, 2015 · US
Enzyme associated with equol synthesis
US8993296B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993296-B2 |
| Application number | US-201414155557-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 15, 2014 |
| Priority date | Dec 27, 2007 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An object of the present invention is to provide enzymes associated with equol synthesis, genes coding such enzymes, and a process for producing equol and its intermediates using the enzymes and genes. The present invention provides a dihydrodaidzein synthesizing enzyme, tetrahydrodaidzein synthesizing enzyme, equol synthesizing enzyme, and genes coding these enzymes. The present invention also provides a process for synthesizing dihydrodaidzein, tetrahydrodaidzein, and/or equol using these enzymes.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated polypeptide comprising an amino acid sequence having at least 80% amino acid identity to the amino acid sequence of SEQ ID NO:13, wherein said isolated polypeptide has an activity of synthesizing equol using tetrahydrodaidzein as a substrate, and wherein said isolated polypeptide does not comprise the amino acid sequence of any of SEQ ID NOs:13-15. 2. A process for producing equol, comprising having the isolated polypepti…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993296B2 cover?
- An object of the present invention is to provide enzymes associated with equol synthesis, genes coding such enzymes, and a process for producing equol and its intermediates using the enzymes and genes. The present invention provides a dihydrodaidzein synthesizing enzyme, tetrahydrodaidzein synthesizing enzyme, equol synthesizing enzyme, and genes coding these enzymes. The present inventio…
- Who is the assignee on this patent?
- Otsuka Pharma Co Ltd
- What technology area does this patent fall under?
- Primary CPC classification C12P17/06. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).